Zebra Medical

Shefayim, Israel Healthcare Acquired

Zebra Medical Vision is an Israeli AI medical imaging company founded in 2014 that developed FDA-cleared deep-learning algorithms to automatically analyze radiology scans (CT, X-ray, mammography) for conditions including cardiovascular disease, liver disease, lung disease, breast cancer, brain bleeds, and vertebral compression fractures. The company built one of the world's largest curated medical imaging research platforms and partnered with health systems globally to power population-health screening. In August 2021, Nanox (NASDAQ: NNOX) agreed to acquire Zebra for up to $200M; the all-stock merger closed in November 2021 and Zebra was rebranded as Nanox.AI, the AI subsidiary of Nano-X Imaging.

Acquired

Zebra Medical has been acquired

Acquired by Nano-X Imaging Ltd. (Nanox) November 8, 2021 Up to ~$200M (all-stock; ~$110M at closing + up to ~$84M in milestone stock)

This company is no longer available on our private secondary market.

Overview

Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Founded

2014

Employees

51–200

Total Funding

$50M

3 rounds

Funding

Total raised $50M across 3 rounds

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Last updated 05-21-2026

Latest Round

Type

Series C

Date

June 7, 2018

Amount

$30M

Valuation

Lead Investors

aMoon
DateRoundAmount RaisedValuationLead Investors
June 7, 2018 Series C $30M aMoon
May 24, 2016 Series B $12M Intermountain Healthcare
April 6, 2015 Series A $8M Khosla Ventures

Leadership

  • Eyal Gura

    Co-Founder

  • Elad Benjamin

    Co-Founder

  • Eyal Toledano

    Co-Founder & CTO

  • Ohad Arazi

    CEO (2020-2021, pre-acquisition)

  • Ran Poliakine

    Chairman & CEO, Nanox (parent)

Competitors

Competitor list is illustrative and may be incomplete, stale, or erroneous.

  • Aidoc

    Israeli AI radiology platform providing FDA-cleared real-time detection of acute findings (intracranial hemorrhage, pulmonary embolism, fractures) integrated into hospital PACS workflow.

  • Viz.ai

    AI-enabled care coordination platform that analyzes medical imaging (notably stroke CT scans) to accelerate triage and treatment decisions.

  • Qure.ai

    Indian AI radiology firm with FDA-cleared chest X-ray and head CT algorithms for TB, stroke, and lung-disease screening in global population-health programs.

  • Lunit

    South Korean public radiology AI company (KOSDAQ: 328130) focused on AI-powered chest X-ray and mammography screening solutions.

  • Annalise.ai

    Harrison.ai-backed radiology AI vendor offering comprehensive chest X-ray and brain CT decision-support covering 100+ findings.

  • Subtle Medical

    AI image-enhancement platform that uses deep learning to accelerate MRI/PET scans and improve image quality at lower dose.

Access live market data

Sign Up

Data collected with AI, which can make mistakes. Please double-check this information.